TD Cowen Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $500
Benzinga Newsdesk 17 hours ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $420 to $500.
TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $420 to $500.